Raymond James Financial Services Advisors, Inc. Statera Biopharma, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$0.13 - $0.28 $1,300 - $2,800
-10,000 Reduced 8.91%
102,250 $13,000
Q1 2022

May 11, 2022
BUY
$0.31 - $2.27 $25,541 - $187,027
82,391 Added 275.93%
112,250 $35,000
Q4 2021

Feb 08, 2022
BUY
$2.01 - $4.08 $35,394 - $71,844
17,609 Added 143.75%
29,859 $69,000
Q3 2021

Nov 02, 2021
BUY
$2.29 - $6.24 $28,052 - $76,440
12,250 New
12,250 $28,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email